Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis

Enhancing cord blood stem cell-derived NK cell growth and differentiation through hyperosmosis

Abstract Background Natural killer (NK) cells hold great promise in treating diverse hematopoietic and solid tumors. Despite their availability from peripheral blood and cord blood, stem cell-derived NK cells offer an 'off-the-shelf' solution. Hematopoietic stem and progenitor cells (HSPCs...

Full description

Bibliographic Details
Main Authors:	Wei Wen, Xiang Chen, Xin-Yi Shen, Hua-Yu Li, Feng Zhang, Feng-Qi Fang, Xiao-Bing Zhang
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Series:	Stem Cell Research & Therapy
Subjects:	Natural killer (NK) cells Hematopoietic stem and progenitor cells (HSPCs) Differentiation Hyperosmosis Immunotherapy
Online Access:	https://doi.org/10.1186/s13287-023-03461-x

Similar Items

Mobilization of Hematopoietic Stem and Progenitor Cells during Dengue Virus Infection
by: Irwin Puc, et al.
Published: (2022-11-01)

Train the Trainer: Hematopoietic Stem Cell Control of Trained Immunity
by: Marco De Zuani, et al.
Published: (2022-01-01)

Wnt9a Is Required for the Aortic Amplification of Nascent Hematopoietic Stem Cells
by: Stephanie Grainger, et al.
Published: (2016-11-01)

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK Cells with Enhanced Antitumor Activity
by: Pranav Oberoi, et al.
Published: (2020-03-01)

Transcriptome sequencing of Verticillium dahliae from a cotton farm reveals positive correlation between virulence and tolerance of sugar-induced hyperosmosis
by: Jin Li, et al.
Published: (2019-11-01)

HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo
by: Sebastian Renelt, et al.
Published: (2022-09-01)

HUMAN NK CELLS: FROM SURFACE RECEPTORS TO THE THERAPY OF LEUKEMIAS AND SOLID TUMORS
by: LORENZO eMORETTA, et al.
Published: (2014-03-01)

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
by: Rasa Islam, et al.
Published: (2021-04-01)

The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
by: Synat Kang, et al.
Published: (2021-02-01)

NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma
by: Ane Orrantia, et al.
Published: (2021-10-01)

CAR-NK cell therapy for glioblastoma: what to do next?
by: Qi Xiong, et al.
Published: (2023-06-01)

Analysis of the impact of handling and culture on the expansion and functionality of NK cells
by: Sara Martin-Iglesias, et al.
Published: (2023-08-01)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
by: Erica L. Heipertz, et al.
Published: (2021-12-01)

Prime editing in hematopoietic stem cells—From ex vivo to in vivo CRISPR-based treatment of blood disorders
by: Jonas Holst Wolff, et al.
Published: (2023-03-01)

Transcriptome Changes of Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of COVID-19 Patients by scRNA-seq
by: Jinfu Zhang, et al.
Published: (2023-06-01)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
by: Eva Persyn, et al.
Published: (2022-09-01)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/-In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
by: Johanna Euchner, et al.
Published: (2021-05-01)

NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression
by: N. A. Alekseeva, et al.
Published: (2023-06-01)

Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy
by: Mubin Tarannum, et al.
Published: (2022-03-01)

TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
by: Hwa-Youn Lee, et al.
Published: (2021-05-01)

Immunotherapeutic Applications of NK Cells
by: Carter T. Davis, et al.
Published: (2015-05-01)

The application of natural killer (NK) cell immunotherapy for the treatment of cancer
by: Rayne H Rouce, et al.
Published: (2015-11-01)

Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation
by: Ki Hyun Park, et al.
Published: (2020-05-01)

SCA-1 Expression Level Identifies Quiescent Hematopoietic Stem and Progenitor Cells
by: Mina N.F. Morcos, et al.
Published: (2017-06-01)

Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation
by: Fei Gao, et al.
Published: (2020-09-01)

CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects
by: Winston Hibler, et al.
Published: (2023-11-01)

Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo
by: Soley Thordardottir, et al.
Published: (2017-03-01)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
by: Raffaella Meazza, et al.
Published: (2023-02-01)

Natural Born Killers: NK Cells in Cancer Therapy
by: S. Elizabeth Franks, et al.
Published: (2020-07-01)

Challenges in Cell Fate Acquisition to Scid-Repopulating Activity from Hemogenic Endothelium of hiPSCs Derived from AML Patients Using Forced Transcription Factor Expression
by: Deanna P. Porras, et al.
Published: (2022-06-01)

PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival
by: Jeremiah L. Oyer, et al.
Published: (2024-04-01)

Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer
by: Minhua Chen, et al.
Published: (2021-11-01)

NK cell-based tumor immunotherapy
by: Hao Zhang, et al.
Published: (2024-01-01)

Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations
by: David S.J. Allan, et al.
Published: (2023-03-01)

WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation
by: Pilar Muñoz, et al.
Published: (2020-12-01)

Improvement of NK Cell Cytotoxicity in Reconstituting NK Cells after Allogeneic Stem Cell Transplantation by Blocking NKG2A Checkpoint
by: Mohammed Taha, et al.
Published: (2023-10-01)

Ricolinostat promotes the generation of megakaryocyte progenitors from human hematopoietic stem and progenitor cells
by: Jianan Jiang, et al.
Published: (2022-02-01)

Fbxw11 impairs the repopulation capacity of hematopoietic stem/progenitor cells
by: Lina Wang, et al.
Published: (2022-06-01)

Cytokine-Induced Memory-Like NK Cells with High Reactivity against Acute Leukemia Blasts and Solid Tumor Cells Suitable for Adoptive Immunotherapy Approaches
by: Matteo Tanzi, et al.
Published: (2021-03-01)

Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
by: Sean J. Judge, et al.
Published: (2020-02-01)